Moving toward implant-agnostic robotic systems

At a Glance 

• Robotic arthroplasty may be moving beyond closed implant ecosystems. 
• Implant-agnostic platforms could expand surgeon choice and personalization. 
• Regulatory and commercial barriers may slow widespread adoption. 

Estimated read time: 5 minutes 

Robotic-assisted arthroplasty has experienced an exponential increase in utilization over the past decade, as well as a plethora of novel iterations of software updates, hardware improvements, and (in some cases) design overhauls. This pattern has enabled many institutions to start viewing robotics less as a purely novel technological adjunct and more as a mainstream component.  

Despite these advances, the current robotic landscape remains fundamentally constrained by the fact that most systems function within a closed implant “ecosystem.” In the U.S. particularly, robotic platforms are typically linked to proprietary implant portfolios, with the robot, planning software, instrumentation, and implants operating as a vertically integrated commercial system.   

This structural constraint raises a critical question about the future direction of the field: Will the next major evolution in arthroplasty robotics be the popularization of implant-agnostic robotic platforms that already exist but are not yet in widespread use? 

Interoperability and modular design provide greater flexibility for surgeons and patients 
The term implant-agnostic robotics refers to systems capable of supporting multiple implant designs rather than functioning exclusively within a single implant family. In theory, such systems would allow surgeons to select implants based on patient anatomy, fixation philosophy, survivorship data, or surgical preference while continuing to use the same robotic platform for planning and execution. Although truly universal systems remain relatively uncommon, there are clear signs that the field is gradually moving toward greater interoperability and more modular robotic architectures. 

The robotic systems currently closest to implant agnosticism in the U.S. are generally not the large-console systems that dominate market share but smaller portable, handheld, or semi-open robotic technologies. These systems often emphasize imageless navigation, compact robotic guidance, modular planning software, and compatibility with broader implant libraries rather than dependence upon a single implant ecosystem. Some handheld wireless robotic systems have explicitly characterized themselves as implant-agnostic technologies within the arthroplasty literature. Unlike traditional closed robotic architectures, these systems are designed around the concept that the robot serves as a navigation and execution platform independent of implant exclusivity. 

This distinction is important because current robotic systems in the U.S. are not merely surgical technologies; rather, they are strategic implant ecosystems. Hospitals adopting a robotic platform frequently enter long-term implant purchasing arrangements aligned with that platform. The robot, therefore, functions not only as a surgical tool but also as a mechanism for implant market consolidation and vendor lock-in. While this structure has accelerated robotic penetration, it has simultaneously limited interoperability and constrained surgeon flexibility regarding implant selection.  

There are several financial models for incorporating robotic arthroplasty into practice, including outright capital purchase, leasing, pay-per-use agreements, and managed service arrangements. More recently, robotics as a service (RaaS) models have gained traction, whereby institutions effectively subscribe to an ecosystem of implants, preoperative planning software, navigation, and robotic execution rather than purchasing the technology outright. However, the lack of widely available implant-agnostic robotic systems presents a significant challenge. Because most robotic platforms are linked to a specific implant manufacturer, institutions seeking access to multiple implant options may be forced to maintain several robotic platforms, each with its own capital costs, service contracts, software subscriptions, disposables, training requirements, and operational workflows. While subscription-based models are intended to lower barriers to adoption, it is not difficult to envision a future in which a practice must subscribe to multiple vendor-specific RaaS ecosystems simply to preserve the flexibility needed to offer patients the most appropriate implant for their individual anatomy, pathology, and reconstructive needs. Such vendor tethering risks increasing costs, operational complexity, and fragmentation of care while potentially constraining surgeon autonomy and patient-specific decision making. 

---
Related Content

• The Economic Impact of Robotic Arthroplasty Systems Is a Hurdle to Adoption, Despite the Technology's Promise (AAOS Now)
• Matthew Deren, MD, shares how he integrated robotics in his total joint arthroplasty practice more than a decade ago (AAOS Now)
• Robotic systems are reshaping practices of early- to mid-career surgeons (AAOS Now)

---

Implant-agnostic systems gain traction in Europe and China
Implant-agnostic and semi-open robotic systems appear to be gaining traction more rapidly outside the U.S., particularly in Europe and China. In Europe, several robotic platforms have emerged with explicit open-platform positioning, emphasizing broader implant compatibility and flexible workflow integration.  

China represents another rapidly evolving frontier in arthroplasty robotics. Over the past several years, Chinese-developed robotic systems have expanded substantially, supported by major national investments in advanced medical technology and domestic manufacturing capability. Several Chinese arthroplasty robotic platforms have achieved both domestic approval and international regulatory certifications, including entry into European markets. Importantly, many of these systems emphasize scalability, affordability, and adaptability to diverse healthcare settings. Rather than functioning solely as implant-delivery ecosystems, these technologies are often positioned as broader orthopaedic robotic and navigation platforms. This distinction may facilitate future implant interoperability and lower barriers to adoption across varying implant preferences. 

Agnostic platforms enable more personalized arthroplasty
There are numerous advantages to implant-agnostic robotic platforms. From a surgeon’s perspective, such systems preserve autonomy in implant selection and surgical philosophy. Indeed, arthroplasty itself is becoming increasingly individualized, with growing adoption of kinematic alignment, restricted kinematic alignment, functional alignment, and patient-specific balancing techniques. As such, many surgeons would benefit from robotic technologies that are capable of adapting to diverse alignment strategies and implant choices rather than constraining workflow around a single implant system. Implant-agnostic systems may therefore better accommodate the continuing evolution of personalized arthroplasty.  

Furthermore, implant choice can be strongly influenced by patient anatomy. For example, proximal femoral morphology may dictate a type of femoral stem that may not conform to the available robotic platform. Having a robotic system that is unconstrained by implant type would provide the surgeon with the armamentarium to manage similar complex cases, with the appropriate implant, coupled with robotic assistance.  

Economic considerations also favor movement toward open robotic platforms. Vendor-specific robotic systems often require substantial capital acquisition costs in addition to recurring service agreements and implant purchasing commitments. Open-platform systems may reduce vendor dependency and potentially improve negotiating flexibility for hospitals and ambulatory surgery centers. Smaller portable robotic systems may additionally reduce infrastructure requirements and facilitate adoption in outpatient settings, community hospitals, and lower-volume practices where large-console systems may be financially impractical. 

From a technological standpoint, implant-agnostic robotics may also facilitate the broader transition toward software-centric arthroplasty. Increasingly, the value proposition of robotics extends beyond simple implant positioning. Contemporary systems incorporate intraoperative analytics, ligament balancing data, artificial intelligence-assisted planning, and workflow integration. Furthermore, the differentiation between systems may shift away from implant exclusivity and toward the intelligence and adaptability of the planning and execution environment itself, which promotes healthy competition and rapid technological advancement. In this future model, the robotic platform effectively functions as a digital operating system while implants become interchangeable hardware components based on surgeon preference and implant-specific pros and cons. 

Regulatory and market hurdles could delay implant-agnostic robotic adoption
Substantial obstacles remain before implant-agnostic robotics can achieve widespread adoption in the U.S. One of the most significant challenges is regulatory complexity. A truly implant-agnostic robotic platform would require validation across numerous implant geometries, fixation methods, instrumentation systems, and surgical workflows. Each implant would require precise digital libraries, calibration parameters, and validated execution pathways. Demonstrating safety and reproducibility across multiple implant combinations would likely require extensive regulatory review and ongoing software validation.  

In addition, commercial realities may ultimately represent an even greater challenge than engineering limitations. Current robotic platforms derive substantial strategic value from their integration with implant sales. Implant-agnostic robotics could disrupt existing market structures, but incumbent stakeholders may possess limited financial incentive to promote interoperability that could erode established commercial advantages. 

Watch for semi-open platforms first
Nevertheless, the trajectory of arthroplasty robotics increasingly suggests movement toward at least partial implant agnosticism. The emergence of portable robotic systems, handheld wireless technologies, open planning architectures, and software-driven surgical ecosystems reflects a broader shift within orthopaedic surgery. The near future may not involve completely universal robotic systems compatible with every implant available; however, a reasonable near-term evolution may consist of semi-open platforms supporting broader implant compatibility and modular planning environments while preserving streamlined workflows. Ultimately, implant-agnostic robotics may represent the natural maturation of robotic arthroplasty.  

Ahmed K. Emara, MD, is a senior orthopaedic surgery resident at Cleveland Clinic. Dr. Emara is chair of the AAOS Resident Assembly Education Committee and a member of the AAOS Now Editorial Board. 

References 

1. Batailler C, White N, Ranaldo L, et al. Handheld wireless robotics in total knee arthroplasty: early multicenter experience with an implant-agnostic robotic system. Arthroplast Today. 2025;31:101654. 
2. Orthopaedic robotic platform receives European regulatory certification for total knee arthroplasty applications. Int J Med Robot Comput Assist Surg. 2024;20(3):e2612. 
3. Hampp EL, Scholl LY, Prieto HA, et al. Robotics in total knee arthroplasty: current concepts and future directions. J Am Acad Orthop Surg. 2022;30(18):e1330-e1340. 
4. Lonner JH. Robotics in total knee arthroplasty: state of the art and future directions. Instr Course Lect. 2023;72:425-438. 
5. Jacofsky DJ, Allen M. Robotics in arthroplasty: a comprehensive review. J Arthroplasty. 2016;31(10):2353-2363. 
6. Sultan AA, Samuel LT, Umpierrez E, et al. Robotic-arm assisted total knee arthroplasty more accurately restores joint line and mechanical alignment than conventional techniques. J Knee Surg. 2020;33(7):633-640. 
7. Marchand RC, Sodhi N, Khlopas A, et al. Coronal correction for severe deformity using robotic-assisted total knee arthroplasty. J Knee Surg. 2019;32(1):2-5. 
8. Kayani B, Konan S, Pietrzak JRT, et al. Robotic-arm assisted total knee arthroplasty improves early functional recovery compared with conventional techniques. Bone Joint J. 2018;100-B(7):930-937.